000			02036 a2200577 4500
005			20250518011902.0
264		0	_c20181231
008			201812s 0 0 eng d
022			_a1178-2013
024	7		_a10.2147/IJN.S181928 _2doi
040			_aNLM _beng _cNLM
100	1		_aChen, Dazhong
245	0	0	_aCodelivery of doxorubicin and elacridar to target both liver cancer cells and stem cells by polylactide-co-glycolide/d-alpha-tocopherol polyethylene glycol 1000 succinate nanoparticles. _h[electronic resource]
260			_bInternational journal of nanomedicine _c2018
300			_a6855-6870 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAcridines _xadministration & dosage
650	0	4	_aAnimals
650	0	4	_aCarcinoma, Hepatocellular _xdrug therapy
650	0	4	_aCell Death _xdrug effects
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aDrug Delivery Systems
650	0	4	_aDrug Synergism
650	0	4	_aEndocytosis _xdrug effects
650	0	4	_aHep G2 Cells
650	0	4	_aHumans
650	0	4	_aLiver Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMice, Nude
650	0	4	_aNanoparticles _xadministration & dosage
650	0	4	_aNeoplastic Stem Cells _xdrug effects
650	0	4	_aPolyesters _xchemistry
650	0	4	_aPolyethylene Glycols _xchemistry
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aStem Cell Transplantation
650	0	4	_aStem Cells _xcytology
650	0	4	_aSubcutaneous Tissue _xdrug effects
650	0	4	_aTetrahydroisoquinolines _xadministration & dosage
650	0	4	_aTissue Distribution
650	0	4	_aTumor Stem Cell Assay
650	0	4	_aVitamin E _xchemistry
700	1		_aPan, Xiaoli
700	1		_aXie, Fangyuan
700	1		_aLu, Ying
700	1		_aZou, Hao
700	1		_aYin, Chuan
700	1		_aZhang, Yu
700	1		_aGao, Jie
773	0		_tInternational journal of nanomedicine _gvol. 13 _gp. 6855-6870
856	4	0	_uhttps://doi.org/10.2147/IJN.S181928 _zAvailable from publisher's website
999			_c29112341 _d29112341